News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Carl Zeiss Meditec AG reduces revenue and EBIT forecast for FY 2023/24 due to slower equipment business recovery. Further cost reduction measures implemented to adjust to market conditions -
-
-
COMMUNIQUÉ DE PRESSE
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects. EBIT margin at 11.4%. Company anticipates revenue acceleration in the second half of 2023/24 -
COMMUNIQUÉ DE PRESSE
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
Carl Zeiss Meditec AG achieved 1.0% revenue growth in the first quarter of fiscal year 2023/24, reaching €475.0m. Earnings before interest and taxes (EBIT) declined to around €43.5m, with the EBIT margin at 9.2%. Revenue growth was primarily boosted by the equipment business and SBU Microsurgery
